Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study by Johanna P. van Gemert, Bart Luijk, Merel E. Hellemons, Klara A. Visser, Carina.M.E. Hansen, Renske van der Meer, C. Tji Gan, Hester van der Vaart, Onno W. Akkerman, Willie N. Steenhuis, Marieke Verkleij, Harry G.M. Heijerman, Erik A.M. Verschuuren

Get full text

The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalization by Chantal Visser, Julia C. Berentschot, Cindy M.M. de Jong, M. Louisa Antoni, L. Martine Bek, Rita J.G. van den Berg-Emons, Bram van den Borst, Hugo ten Cate, Arina J. ten Cate-Hoek, Dionne C.W. Braeken, J.J. Miranda Geelhoed, Majanka H. Heijenbrok-Kal, Sander M.J. van Kuijk, Lucia J.M. Kroft, Jenneke Leentjens, Anna H.E. Roukens, Suzanne C. Cannegieter, Frederikus A. Klok, Marieke J.H.A. Kruip, Merel E. Hellemons

Get full text